ALUR
Allurion Technologies Inc

2,300
Mkt Cap
$14.37M
Volume
1.06M
52W High
$4.18
52W Low
$0.95
PE Ratio
-0.16
ALUR Fundamentals
Price
$1.17
Prev Close
$1.25
Open
$1.25
50D MA
$1.40
Beta
1.16
Avg. Volume
109,914.40
EPS (Annual)
-$3.20
P/B
-0.11
Rev/Employee
$234,379.56
$46.70
Loading...
Loading...
News
all
press releases
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
Here is how Allurion Technologies, Inc. (ALUR) and McKesson (MCK) have performed compared to their sector so far this year.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
Allurion Technologies, Inc. (NYSE: ALUR) (the Company or Allurion), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of...
Business Wire·6d ago
News Placeholder
Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout
As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.
24-7 Market News·6d ago
News Placeholder
Why Did Allurion Stock Surge Over 50% Today?
The U.S. Food and Drug Administration has granted premarket approval for Allurion’s Gastric Balloon System with the swallowable Allurion Smart Capsule.
Stocktwits·7d ago
News Placeholder
Allurion Receives U.S. FDA Approval
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA...
Business Wire·7d ago
News Placeholder
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro (tirzepatide) at Discounted Prices
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a partnership with Bionut, a leader in obesity care in Argentina, and Farmastar, a local...
Business Wire·27d ago
News Placeholder
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced preliminary, unaudited results for the fourth quarter and full year 2025. Management expects...
Business Wire·2mo ago
News Placeholder
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of a peer-reviewed, case-controlled study on the use of the Allurion Smart...
Business Wire·3mo ago
News Placeholder
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device...
Business Wire·3mo ago
News Placeholder
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.
Zacks·3mo ago
<
1
2
...
>

Latest ALUR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.